Loading
08:30
  1. Registration & networking
    Business Centre: Lower Ground Floor
    30 mins
    • Investment Summit
    Registration
09:00
  1. Pau Casals
    15 mins
    • Investment Summit

    A VC leader or industry analyst to set the tone, covering the investment climate for advanced therapies, emerging hotspots and why early-stage innovation is still worth investing in

10:00
  1. Pau Casals
    40 mins
    • Investment Summit

    A showcase from 2 early-stage biotech’s outlining not just what they want from funding partners but what they need – mentorship, guidance, expertise and access to networks

10:40
  1. Pau Casals
    35 mins
    • Investment Summit

    A candid conversation between a biotech founder and their early investor exploring the startup journey

11:15
  1. Refreshment & networking break
    Pau Casals
    25 mins
    • Investment Summit
    1-2-1 Meetings
12:50
  1. Pau Casals
    5 mins
    • Investment Summit
    Wrap up from senior VC – covering the landscape of what’s next and where biotech investment will grow for the next 5 years
13:00
  1. Investment Summit & Women In Advanced Therapies Lunch
    Pau Casals
    60 mins
    • Investment Summit
    • Women in Advanced Therapies
    Lunch break and networking
14:45
  1. Networking break
    Pau Casals
    15 mins
    • Women in Advanced Therapies
    1-2-1 Meetings
15:00
  1. Pau Casals
    45 mins
    • Women in Advanced Therapies
  2. Pau Casals
    45 mins
    • Women in Advanced Therapies
  3. Pau Casals
    45 mins
    • Women in Advanced Therapies
  4. Pau Casals
    45 mins
    • Women in Advanced Therapies
  5. Pau Casals
    45 mins
    • Women in Advanced Therapies
  6. Pau Casals
    45 mins
    • Women in Advanced Therapies
  7. Pau Casals
    45 mins
    • Women in Advanced Therapies
  8. Pau Casals
    45 mins
    • Women in Advanced Therapies
  9. Pau Casals
    45 mins
    • Women in Advanced Therapies
  10. Pau Casals
    45 mins
    • Women in Advanced Therapies
15:45
  1. Refreshment & networking break
    Pau Casals
    20 mins
    • Women in Advanced Therapies
    1-2-1 Meetings
16:05
  1. Pau Casals
    50 mins
    • Women in Advanced Therapies

    Following on from the earlier roundtables, the moderator from each table will share the key points from the discussion. Enabling audience members to receive insights across all topics and encouraging further discussion post-event.

16:55
  1. Pau Casals
    20 mins
    • Women in Advanced Therapies
    • Building resilience and strategy crucial for long term success 

    • Navigating uncertainty and leading with confidence 

    • Owning your leadership style and being a successful leader 

17:15
  1. Pau Casals
    10 mins
    • Women in Advanced Therapies
    Closing address
17:30
  1. Rooftop pool - Hotel Arts
    90 mins
    • Networking
    Join us for an unforgettable evening overlooking the marina at the iconic Hotel Arts Barcelona. Connect with fellow attendees – expect great impressive views, great conversation, and a few surprises a ...
08:00
  1. Partnering room located in the Pau Casals Ballroom
    60 mins
    • Workshop
    Workshop by Catapult - description to follow
    Catapult
  2. Exhibition Hall
    60 mins
    • Networking
09:10
  1. Plenary
    45 mins
    • Plenary
    This session will explore the current state of the CGT industry, with a focus on Europe’s evolving role amid global shifts. In a climate where research ecosystems face mounting uncertainty — particularly following moves in the U.S. to scale back federal support for scientific innovation, Europe must sharpen its competitiveness to secure its leadership in advanced therapies. We will examine emerging trends, key market dynamics, and the urgent need for Europe to overcome challenges around scalability, affordability, and patient access. The discussion will highlight how external pressures are reshaping Europe’s strategic priorities — and what actions are needed now to turn today’s challenges into tomorrow’s leadership in CGT. 
09:55
  1. Plenary
    35 mins
    • Plenary

    Deep dive into the regulatory framework that governs CGT across major rejoins, focusing on recent updates, new legislation and how companies can navigate the changing landscape.

10:30
  1. Coffee and networking break
    Exhibition Hall
    30 mins
    • Networking
10:59
  1. Theatre 1
    1 mins
    • R&D, clinical innovation & translation
  2. Theatre 2
    1 mins
    • Manufacturing, scale up & commercial strategy
  3. Theatre 1
    1 mins
    • Workshop
11:00
  1. Theatre 1
    35 mins
    • R&D, clinical innovation & translation
    • Cutting edge developments in CRISPR, gene editing and cell engineering
    • The next wave of in vivo and ex vivo gene therapies
    • What breakthroughs are expected to reshape the industry?
  2. Theatre 2
    35 mins
    • Manufacturing, scale up & commercial strategy
    • As the pressure mounts to deliver advanced therapies faster, cheaper, and closer to the patient, decentralised manufacturing is stepping into the spotlight. But does breaking away from centralised models really deliver on cost? 

    • This panel dives into the economic realities behind the decentralisation trend. Are localised manufacturing hubs the answer to cutting costs, or do they introduce new layers of complexity and hidden spend? From infrastructure investments to regulatory headaches, we’ll separate financial fact from fiction and explore whether decentralisation is a bold leap forward or an expensive detour. 

  3. Partnering room located in the Pau Casals Ballroom
    35 mins
    • Workshop

    Highlight how the UK is strengthening its ATMP ecosystem through coordinated infrastructure, regulatory agility, and health system integration — with a forward-looking, opportunity-driven lens.

11:40
  1. Theatre 1
    15 mins
    • R&D, clinical innovation & translation
  2. Theatre 2
    15 mins
    • Manufacturing, scale up & commercial strategy
    The development and manufacturing of chimeric antigen receptor T cells (CAR-T) using established methods is resource intensive and logistically demanding. This showcase presentation will focus on demo ...
  3. Partnering room located in the Pau Casals Ballroom
    35 mins
    • Workshop

    Showcase how Nordic countries are combining national strengths in biomanufacturing, data infrastructure, and public-private partnerships to build a regional ATMP hub.

12:00
  1. Theatre 1
    15 mins
    • R&D, clinical innovation & translation
  2. Theatre 2
    15 mins
    • Manufacturing, scale up & commercial strategy
    Despite numerous approvals from the European Medicines Agency (EMA), patient access to cell and gene therapies across Europe faces significant delays. On average, these therapies take 578 days to beco ...
12:20
  1. Theatre 1
    40 mins
    • R&D, clinical innovation & translation
    • Why characterisation and analytics remain a major hurdle. 

    • Collaborative approaches to tackling technical challenges 

    • Best practices and emerging solutions. 

  2. Theatre 2
    40 mins
    • Manufacturing, scale up & commercial strategy
    • Balancing technical and financial realities in manufacturing
    • When to invest in infrastructure vs outsourcing
    • The role of automation in optimising CMC process
13:00
  1. Partnering room located in the Pau Casals Ballroom
    60 mins
    • Workshop
    Genomic medicine at the crossroads: Innovation meets regulation
    Cytiva
  2. Lunch & networking break
    Exhibition Hall
    60 mins
    • Networking
    1-2-1 meetings
14:00
  1. Theatre 1
    40 mins
    • R&D, clinical innovation & translation
    • How startups secure investment before reaching human trials 

    • strategic and tactical guidance on how to secure the right funding at the right time, from seed rounds through Series A 

    • Investor insights into due diligence, risk mitigation and valuation and what good really looks like  

  2. Theatre 2
    40 mins
    • Manufacturing, scale up & commercial strategy
    • Transitioning from academic proof of concept to market-ready product 

    • Why biotech teams must integrate CMC, regulatory and pharmacology early 

    • Avoiding pitfalls of overselling and overpromising 

15:05
  1. Theatre 1
    15 mins
    • R&D, clinical innovation & translation
  2. Theatre 2
    15 mins
    • Manufacturing, scale up & commercial strategy
    Cell therapies through their curative potential offer life-changing treatment options to patients with no other recourse. In a few short years, they have achieved unprecedented success as evidenced by ...
15:40
  1. Coffee break & networking
    Exhibition Hall
    35 mins
    • Networking
    1-2-1 Meetings
16:15
  1. Plenary
    45 mins
    • Plenary

    Our interactive roundtables are designed with you in mind. Dive into dynamic, interactive discussions tailored to your interests. Select the table that sparks your curiosity, engage with like-minded professionals, and be part of a conversation that’s both insightful and impactful.  

     

  2. Partnering room located in the Pau Casals Ballroom
    45 mins
    • Workshop
     Explore Spain’s growing potential as a strategic ATMP manufacturing and clinical trial hub within the EU.
17:00
  1. Networking Happy Hour
    Exhibition Hall
    120 mins
    • Networking
08:00
  1. Partnering room located in the Pau Casals Ballroom
    60 mins
    • Workshop
     Key considerations for late-phase and commercial AAV gene therapy manufacturing
    Catalent
09:10
  1. Innovation exchange
    Plenary
    80 mins
    • Plenary
    Join us for an exciting session where innovative biotech start-ups pitch their groundbreaking ideas and solutions. Watch as they present to a panel of expert investors, who will provide real-time feedback, insights, and guidance. This is a unique opportunity to explore cutting-edge advancements in the biotech space and gain valuable perspectives from both entrepreneurs and industry leaders. 
    Sponsored by Medicpres
10:30
  1. Plenary
    45 mins
    • Plenary
    Today's CGT startups are facing the toughest fundraising environment in years — and solid science alone isn’t enough. This panel digs into the hard truths: How the market squeeze is reshaping funding dynamics, why traditional playbooks aren't working, and what it takes to stand out when investors are more selective than ever. Real stories. Real setbacks. Real strategies for surviving and scaling in a high-stakes market. 
11:15
  1. Networking & coffee break
    Exhibition Hall
    30 mins
    • Networking
11:44
  1. Theatre 1
    1 mins
    • R&D, clinical innovation & translation
  2. Theatre 2
    1 mins
    • Manufacturing, scale up & commercial strategy
11:45
  1. Theatre 1
    15 mins
    • R&D, clinical innovation & translation
  2. Theatre 2
    15 mins
    • Manufacturing, scale up & commercial strategy
  3. Partnering room
    55 mins
    • Workshop
    A closed-door, outcome-driven discussion aligning top industry leaders around immediate actions to implement ARM’s EU Policy Blueprint and unlock scalable patient access across Europe.
13:15
  1. Partnering room located in the Pau Casals Ballroom
    60 mins
    • Workshop

    A Case Study and Panel Discussion featuring ADVA X3 from Adva Biotechnology, and Autolomate from Autolomous

  2. Lunch break
    Exhibition Hall
    60 mins
    • Networking
    1-2-1 meetings
14:25
  1. Plenary
    35 mins
    • Plenary
    AI is everywhere, but in CGT, real deployment remains limited. This session goes beyond the buzz to explore the tangible opportunities, early wins, and critical barriers to broader adoption. We’ll loo ...
15:00
  1. Plenary
    35 mins
    • Plenary
    As we wrap up two days of deep discussions on the current state of the European CGT landscape, this final panel will chart the path ahead. Which steps must Europe take to remain competitive and lead the way in the next 5–10 years? Each panellist will share their key takeaways from the last two days, reflecting on the insights, challenges, and opportunities discussed.